Neuroimaging and Genetics of Antidepressant Response to Sleep Deprivation: Implications for Drug Development

E-ISSN： 1873-4286|15|22|2637-2649

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.22, 2009-08, pp. : 2637-2649

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The dopamine system is involved in antidepressant sleep deprivation - a possible mechanismon of antidepressant action?

By Ebert D. Albert R. May A. Kaschka W.P. Barocka A.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 285-286

Elsevier

Access to resources Recommend Favorite

Role of Neuroimaging in Analgesic Drug Development

By Lawrence Jane Mackey Sean C.

Drugs in R&D, Vol. 9, Iss. 5, 2008-01 ,pp. : 323-334

Adis International

Access to resources Recommend Favorite

The Glutamate Hypothesis of Schizophrenia: Neuroimaging and Drug Development

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 8, 2012-06 ,pp. : 1500-1512

Bentham Science Publishers

Access to resources Recommend Favorite

Antidepressant therapy: new targets for drug development

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 11, 2001-11 ,pp. : 1693-1711

Informa Healthcare

Access to resources Recommend Favorite

Clinical Perspectives on Antidepressant Drug Development: A Critical Discussion

Current Pharmaceutical Design, Vol. 11, Iss. 2, 2005-01 ,pp. : 227-231

Bentham Science Publishers

Access to resources Recommend Favorite